India, Sept. 23 -- Lord's Mark Industries in collaboration with the Centre for Materials for Electronic Technology (C-MET), has advanced its AI-powered, radiation-free wearable breast cancer screening technology towards its final clinical trial stage, with trials planned across the USA, Great Britain and Europe.Developed using high-precision thermal sensors and AI-driven temperature mapping, the technology is designed to identify abnormalities associated with breast cancer in a non-invasive and radiation-free manner.The technology has undergone high accuracy and conformity testing, with Lord's Mark Industries holding exclusive rights for its commercialisation. Phase 2 trials for detection of cancer at the cell level, targeting 98% accuracy,...